RxDoctor Payments Data

Andrea Cass, DPM

Podiatrist · Smyrna, GANPI 1942447446

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,178 of the $4,471 with a category attached, or 71.1%. 19 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 25.0% of the total.

$4,471in general payments, 2019–2025

Across 90 payments — averaging $49.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$1K
  • Smith+Nephew$889
  • Medical Device Business Services, Inc.$880
  • Bioventus LLC$282
  • Geistlich Pharma, North America, Inc.$250
  • Johnson & Johnson$233
  • plus $818 from 13 others

What the payments were for

  • Consulting fees$88020%
  • Travel & lodging$4139%
  • Food & beverage$3,17871%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,471 in reported general payments places this provider in the 70th percentile of 177 podiatrist providers in Georgia.

See all podiatrist providers in Georgia

Medicare billing

Part B allowed, 2024
$282,180
Medicare patients
995
Services billed
3,246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox50$1,285
Ketoconazole42$889
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen60$738
Gabapentin67$608
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$297
Terbinafine Hcl55$278
Mupirocin20$137
Doxycycline Hyclate15$127
Ondansetron Hcl19$52
Tramadol Hcl12$36
Meloxicam26$31

Paid to pharmacies, not to this prescriber.

Other podiatrist in Smyrna

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →